Acquisition of Medicines and Supplies by Supreme Decree 4505 for the Hemodialisis Unit of the Second Level Hospital Mining Barrios

BoliviaTenders notice for Acquisition of Medicines and Supplies by Supreme Decree 4505 for the Hemodialisis Unit of the Second Level Hospital Mining Barrios. The reference ID of the tender is 125469664 and it is closing on 02 Sep 2025.

100% Secure Payments

Tender Details

  • Country: Bolivia
  • Summary: Acquisition of Medicines and Supplies by Supreme Decree 4505 for the Hemodialisis Unit of the Second Level Hospital Mining Barrios
  • BOT Ref No: 125469664
  • Deadline: 02 Sep 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 25-1401-00-1589327-1-1
  • Purchaser's Detail :
  • Purchaser : ORURO MUNICIPAL AUTONOMOUS GOVERNMENT
    Victor Antonio Mendoza Mendoza (telf 2-5251624)

  • Description :
  • The bidders are invited to acquisition of medicines and supplies by Supreme Decree 4505 for the Hemmodialysis Unit of the Second Level Hospital Mining Neighborhoods
    2025
    : CNC
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
BoliviaTenders Features

BoliviaTenders Features

Fresh and verified Tenders from Bolivia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Bolivia in your email inbox.

  Chat with us